Quarterly report [Sections 13 or 15(d)]

Asset Purchase and Merger Agreements - Checkpoint CVR Agreement (Details)

v3.25.3
Asset Purchase and Merger Agreements - Checkpoint CVR Agreement (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 9 Months Ended
May 30, 2025
Mar. 09, 2025
Jul. 31, 2025
Jun. 30, 2025
Sep. 30, 2025
Sep. 30, 2024
Business Combination [Line Items]            
Other liabilities         $ (1,509) $ 735
Noncontrolling Interest, Decrease from Deconsolidation         9,931  
Gain from deconsolidation of subsidiary         $ 27,127 $ 0
Checkpoint Merger            
Business Combination [Line Items]            
Proceeds from sale of subsidiary interests     $ 2,900 $ 25,100    
Other liabilities $ 10,800          
Noncontrolling Interest, Decrease from Deconsolidation $ 9,900          
Checkpoint Merger            
Business Combination [Line Items]            
Excess over per share exercise price for warrants   $ 4.1        
Cash payment per share   $ 3.62        
Warrants issued   5,853,659        
Checkpoint Merger | Checkpoint Merger | Sun Pharmaceutical Industries, Inc.            
Business Combination [Line Items]            
Stock purchase, price per share   $ 4.1        
Maximum contingent consideration per each outstanding share   $ 0.7        
Milestone deadline date determination term   36 months        
Checkpoint Merger | Checkpoint Merger | Sun Pharmaceutical Industries, Inc. | If Milestone is first achieved on or prior to date that is 12 months prior to Milestone Deadline Date and approval for a dosing schedule of once every three weeks            
Business Combination [Line Items]            
Contingent cash consideration upon achievement of milestone   $ 700        
Checkpoint Merger | Checkpoint Merger | Sun Pharmaceutical Industries, Inc. | If Milestone is first achieved on or prior to date that is 12 months prior to Milestone Deadline Date and approval for a dosing schedule of more frequent than once every three weeks            
Business Combination [Line Items]            
Contingent cash consideration upon achievement of milestone   450        
Checkpoint Merger | Checkpoint Merger | Sun Pharmaceutical Industries, Inc. | If Milestone is first achieved on or after the date that is 12 months prior to Milestone Deadline Date and approval for a dosing schedule once every three weeks            
Business Combination [Line Items]            
Contingent cash consideration upon achievement of milestone   450        
Checkpoint Merger | Checkpoint Merger | Sun Pharmaceutical Industries, Inc. | If Milestone is first achieved on or after the date that is 12 months prior to Milestone Deadline Date and approval for a dosing schedule more frequent than once every three weeks            
Business Combination [Line Items]            
Contingent cash consideration upon achievement of milestone   $ 200